EUROAPI Appoints New Executive Committee Members
28 November 2023 - 8:00AM
Business Wire
Regulatory News:
EUROAPI (Paris:EAPI) today announced the appointment of David
Seignolle as Chief Operating Officer, succeeding Eric Berger, and
Marion Santin as Chief Legal, Compliance, and IP Officer, both
joining the company’s Executive Committee.
In his new role, David Seignolle will lead the transformation of
the Industrial Operations organization, focusing on reinforcing
robustness and compliance on the entire end-to-end supply chain
whilst bringing relevant innovation and product development to
support the company's ambition. He will actively oversee the
industrial execution of the strategic review announced on October
9, 2023.
“David brings extensive and international experience in
industrial operations, with a particular focus on large
transformation of organizations. His expertise will be instrumental
in our ambition to adapt the company’s operating model in a rapidly
evolving environment,” said Viviane Monges, EUROAPI’s Chief
Executive Officer. “David and Marion add great value to our
Executive Committee. I also want to use this opportunity to thank
Eric for his many contributions to the creation, listing and
management of EUROAPI.”
David Seignolle, Chief Operating Officer
David Seignolle, a French citizen, joins EUROAPI from Bain &
Company where he served as Expert Partner in the Healthcare
Practice. Prior to this, David spent 6 years at TEVA where he held
several positions such as Head of Operations for Teva API in Italy
and Mexico, Vice President Global Supply Chain API and Biologics or
Site General Manager. David has also served 5 years at McKinsey
& Company in France and in the US where he was focusing on
Pharma Operations after beginning his career in Procurement at
Toyota Motor Europe. David has a degree in Mechanical Engineering
& Industrial Science as well as a postmaster degree in
International Procurement Management.
Marion Santin, Chief Legal, Compliance, and IP
Officer
Marion Santin, a French citizen, began her career as an
associate in law firms, first at Kramer Levin Naftalis &
Frankel LLP and then at DLA Piper. She then joined Sanofi in 2006,
where she first held the position of Industrial Affairs Legal
Manager, then Alliances & Partnerships Legal Director, Mergers
& Acquisitions Legal Director before becoming Commercial
Operations Legal Director for the legal teams based in Asia, the
Middle East, India, Hong Kong and Taiwan. Marion holds an Advanced
Degree in Business Law and a Magistère in Business Law from the
University of Paris I - Panthéon-Sorbonne. Marion is also a member
of the Paris Bar.
About EUROAPI
EUROAPI is focused on reinventing active ingredient solutions to
sustainably meet customers’ and patients’ needs around the world.
We are a leading player in active pharmaceutical ingredients with
approximately 200 products in our portfolio, offering a large span
of technologies, while developing innovative molecules through our
Contract Development and Manufacturing Organization (CDMO)
activities.
Taking action for health by enabling access to essential
therapies inspires our 3,450 people every day. With strong research
and development capabilities and six manufacturing sites all
located in Europe, EUROAPI ensures API manufacturing of the highest
quality to supply customers in more than 80 countries. EUROAPI is
listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find
out more at www.euroapi.com and follow us on LinkedIn.
Forward-Looking Statements
Certain information contained in this press release is forward
looking and not historical data. These forward-looking statements
are based on opinions, projections and current assumptions
including, but not limited to, assumptions concerning the Group’s
current and future strategy, financial and non-financial future
results and the environment in which the Group operates, as well as
events, operations, future services or product development and
potential. Forward-looking statements are generally identified by
the words “expects”, “anticipates”, “believes”, “intends”,
“estimates”, “plans” and similar expressions. Forward looking
statements and information do not constitute guarantees of future
performances, and are subject to known or unknown risks,
uncertainties and other factors, a large number of which are
difficult to predict and generally outside the control of the
Group, which could cause actual results, performances or
achievements, or the results of the sector or other events, to
differ materially from those described or suggested by these
forward-looking statements. These risks and uncertainties include
those that are indicated and detailed in Chapter 3 “Risk factors”
of the Universal Registration Document approved by the French
Financial Markets Authority (Autorité des marchés financiers, AMF)
on April 14, 2023, under number R.23-009 and the Amendment to
Universal Registration Document approved by the AMF on April 25,
2023 under number R.23-015. These forward-looking statements are
given only as of the date of this press release and the Group
expressly declines any obligation or commitment to publish updates
or corrections of the forward-looking statements included in this
press release in order to reflect any change affecting the
forecasts or events, conditions or circumstances on which these
forward-looking statements are based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231127207313/en/
Media Relations Contact: Laurence Bollack Mob.: +33 (0)6
81 86 80 19 mr@euroapi.com
Investor Relations Contact: Sophie Palliez-Capian Mob.:
+33 (0)6 87 89 33 51 sophie.palliez@euroapi.com
Euroapi (EU:EAPI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Euroapi (EU:EAPI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024